Vuronyx technologies proposes to develop acetylperoxyborate (APB) powders for disinfection of personal protective equipments (ppes) so that the ppes can be reused

The National Institute of Standards and Technology awarded Vuronyx Technologies LLC a $1,599,940.60 cooperative agreement under the Science, Technology, Business and/or Education Outreach program (CFDA 11.620) to develop acetylperoxyborate (APB) powders for disinfecting personal protective equipment. Vuronyx will perform efficacy testing of APB powders against viruses on test coupons and evaluate resulting byproducts and residues. It will also evaluate the structural integrity of N95 masks and Tyvek suits treated with APB powders. The University of Massachusetts Lowell was awarded a subagreement to perform testing on complete PPE items. If successful, Vuronyx's APB powders could generate a liquid solution to disinfect a wide range of microbes and help address supply chain issues with PPE, benefiting industries where decontamination is needed.

Activities

During phase i, vuronyx will perform the following activities:1. Efficacy testing on test coupons against various viruses.2. Evaluate byproducts and residues.3. Evaluate structural integrity for N95 and tyvek suits.during phase II, vuronyx will perform the following activities:1. Perform efficacy testing on complete PPE items.

Expected outcomes

Vuronyx technologies plans to develop a powder based formulation that will generate a liquid solution that can disinfect a wide range of microbes. Vuronyx also purports that its proposal is aligned with the goal of reducing supply chain issues with ppes.

Intended beneficiaries

Vuronyx?s technology will benefit most industries where decontamination of PPE?s is needed, including US military field hospitals, mass casualty situations, third world countries, civilian markets such as rural clinics, and agencies such as FEMA and the red cross.

Subrecipient activities

The subcontractor selected for phases i and II is the university of massachusetts, lowell who will be performing testing on PPE?s. 4) tartan silicon systems:purpose: in phase i, tartan silicon systems, INC., plans to provide a proof of concept that demonstrates the feasibility of placing sensor technology on a system on a chip (SOC) to improve yield, quality, and the ability to predict SOC failure in due to wear out mechanisms.

Activities

Activities to performed in phases i and II are as follows:phase i: develop and verify an nbti sensor that can be integrated on system on a chip (SOC). This objective is to develop and verify in simulation a sensor that will be useful to monitor the health of a semiconductor device.phase II: develop an nbti spice simulation model. Tartan proposes to develop and use a simulation model for its the nbti sensor.

Expected outcomes

The potential applications resulting from this research effort will supplement the design process of semiconductors through integration of process sensors into socs, aggregating process data and functional data using conventional production flows for yield and quality improvement, and an ability to generate in situ tunable device models to optimize performance, thereby improving yield and device quality.

Intended beneficiaries

This effort will impact mission critical applications such as automotive, enterprise computing and networking, and military.

Subrecipient activities

Tartan silicon has not provided a proposal for subrecipient activities.5) ratiocinative engineering services LLC:purpose: the purpose of ratiocinative engineering services LLC?s (ratioc) proposal is to develop a testbed that will lead to more accessible and robust quality control testing of air filtration and ventilation systems in actual built environments, thus responding to the need for air filtration to remove coronavirus or other airborne infectious diseases from indoor air spaces for people.

Activities

Activities to performed in phases i and II are as follows:phase i: to test the feasibility of an air filtration testbed (including a particle generator and detection system) for efficacy at removing proxy infectious p